How is the Precision Medicine Initiative Supporting Cancer Research?
The Precision Medicine Initiative (PMI) was launched by the U.S. government to accelerate biomedical research and provide clinicians with new tools to select the therapies that will work best for individual patients. In the context of cancer, the PMI has supported numerous research projects aimed at understanding the genetic and molecular basis of different cancers. This research is crucial for developing new, more effective treatments and for identifying biomarkers that can guide therapy choices.
